Samenvatting
Summary MS Clinical immunology (AM_470655)
- Instelling
- Vrije Universiteit Amsterdam (VU)
I have summarized the 8 lectures on the basis of powerpoints and recordings of the lectures.
[Meer zien]Voorbeeld 4 van de 31 pagina's
Voorbeeld 4 van de 31 pagina's
In winkelwagengesponsord bericht van onze partner
Verkoper
Volgen
Voorbeeld van de inhoud
HC1 Clinical Introduction to Multiple SclerosisEpidemiology:
There are 2-3 million MS-patients globally, in the Netherlands is that 1/2:1000 patients.
3:1 woman:men ratio (because of the hormones) and MS patients are 20-40 years old.
MS is a ‘western’ disease. Countries like china have low rates of MS.
Pathology:
MS is a disease of the central nervous system: brain and the spinal cord.
- The myelin around the axons is attacked by our own immune system.
Myelin is needed for quick signaling over the axon.
o Myelin is attacked = demyelination
Lesions can happen in the white matter, brain stam, cortex or spinal cord…
Axonal degeneration = loss of brain tissue
Cause:
1. Genetic factors: monozygotic twin has a very high chance of also getting MS, but if
one parent has MS the chance is much lower.
2. Environmental factors
o Vitamin D
o Smoking
o Early obesity
o Virus: EBV
Symptoms:
1. Optic neuritis:
o Decreased sharp sight, especially in the center
o Disturbance of color vision
o Pain behind the eye
2. Eye movement impairment:
o A patient with dubble vision and both eyes does not
move at the same time (congregate).
This can mean that there is demyelination in the
brain stam.
→ Internuclear ophthalmoplegia (INO)
, 3. Lhermitte’s symptoms: lesions in the spinal cord, pain when they bend their
nek/back. This will cause an electric shock.
4. Motor functions impairment: lesions from the brain to the spinal cord. The location
of the lesion determines the affected motor function.
5. Bladder dysfunction: lesions in the lower spinal cord, sacral 2, 3, 4.
6. Psychological functions (common in 45-65%):
o Slowing of processing
o Attention deficit
o Disturbances of memory
o Disturbances of language functions
7. Fatigue: high prevalence, high impact for patients, but cause unknown
Diagnosis MS:
Remitting Relapsing MS (RRMS): patients can recover from the relapses. This phase can turn
into secondary progressive MS (SPMS), in this phase the patient cannot recover anymore.
The clinical symptoms are then higher than the clinical threshold, this can involve a walking
stick or wheelchair.
1. Remitting Relapsing MS
2. Secondary progressive MS
3. Primary progressive MS
,Dysfunction of variable areas of brain or spinal cord at more than one occasion in time:
→ Dissemination (verspreiding) in space and in time.
- Space: diagnosis with MRI (more than one lesion in one area)
- Time: > 1 relapses
o MRI: new lesions on follow-up MRI or contrast enhancing and non-contrast
enhancing (previous before the contrast lesions) lesions at the same time.
o Oligoclonal bands in the cerebrospinal fluid
Cerebrospinal fluid is obtained by a lumber biopsy in the spinal cord
1. Oligoclonal bands (IEF):
• sensitivity ± 90%
• specificity much lower
2. IgG-index
• sensitivity ± 65%
• even lower specificity
Oligoclonal bands: proteins in the cerebrospinal fluid secreted by the auto-antibodies.
Follow-up:
- Once a year or earlier when the patient asks for contact an appointment.
o Clinical, MRI, biochemical
, HC2 MS and therapy
MS is in a later phase very difficult to treat. This is the secondary progressive phase, where
the patient does not recover by themselves. This is the reason why the most treatments are
focused on the beginning of the disease, the relapsing-remitting phase.
Areas for therapy for MS:
Exacerbations
- Treatment of symptoms during exacerbations
- Steroids: 500-1000 mg IV 3-5 days
Symptomatic treatment
- Treatment of spasticity, urinary incontinence, pain etc..
Immunomodulation
- Prevention of exacerbations/relapses
There are a lot of drugs for treating MS:
- Switched to an earlier stage of the disease starting treatment
o Sooner: clinically isolated syndrome
- More agressive: Radiologically stable
- Continue for longer
→ The drugs for MS are very expensive.
Patient X = 28 years old
MRI shows demeylation regions
- Spinal fluid: oligoclonal bands in CSF
Conclusion: active RRMS
How would you choose the treatment?
- Effectiveness vs risk (side-effects)
- Short or long term: patient will be happy now but develop complications later on
- Mode of administration: pills, visit the hospital or injections
- Costs
Early therapy is important to delay the
accumulation of irreversible neurologic
damage and consequent disability.
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper Laurageerlings2000. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €4,99. Je zit daarna nergens aan vast.
Is Stuvia te vertrouwen?
4,6 sterren op Google & Trustpilot (+1000 reviews)
Afgelopen 30 dagen zijn er 52510 samenvattingen verkocht
Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen